While I did enjoy reading your summary of the updated Pharmaceutical Research and Manufacturers of America's Code on Interactions with Healthcare Professionals (“Danger Zone,” September/October 2008), it does sadden me that we as a profession have gotten to this point. I am unaware of any physician who makes any prescribing choices based on what drug is named on his or her pen. When the pen is empty, it is discarded and we reach for another one. The idea that the drug name or company logo is ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Printer-friendly, you'll get exclusive access to a large archive of premium content.

Already registered? here.